Growing community of inventors

Grand Rapids, MI, United States of America

Nicholas S Duesbery

Average Co-Inventor Count = 4.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 11

Nicholas S DuesberyStephen H Leppla (5 patents)Nicholas S DuesberyCraig P Webb (5 patents)Nicholas S DuesberyGeorge Vande Woude (4 patents)Nicholas S DuesberyGeorge F Vande Woude (2 patents)Nicholas S DuesberyHan-Mo Koo (1 patent)Nicholas S DuesberyEunmi (Kay) Koo, Legal Representative (1 patent)Nicholas S DuesberyNicholas S Duesbery (6 patents)Stephen H LepplaStephen H Leppla (37 patents)Craig P WebbCraig P Webb (6 patents)George Vande WoudeGeorge Vande Woude (5 patents)George F Vande WoudeGeorge F Vande Woude (14 patents)Han-Mo KooHan-Mo Koo (1 patent)Eunmi (Kay) Koo, Legal RepresentativeEunmi (Kay) Koo, Legal Representative (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. National Institutes of Health, a Component of the US Dept. of Health & Human Services (5 from 3,435 patents)

2. Van Andel Research Institute (1 from 26 patents)


6 patents:

1. 7612035 - Inhibition of mitogen-activated protein kinase (MAPK) pathway: a selective therapeutic strategy against melanoma

2. 7183071 - Anthrax lethal factor is a MAPK kinase protease

3. 7056693 - Anthrax lethal factor is a mapk kinase protease

4. 6911203 - Anthrax lethal factor is a MAPK kinase protease

5. 6893835 - Anthrax lethal factor is a MAPK kinase protease

6. 6485925 - Anthrax lethal factor is a MAPK kinase protease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…